HighMark Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121K Buy
1,397
+45
+3% +$4.31K 0.05% 101
2025
Q4
$130K Buy
1,352
+10
+0.7% +$971 0.05% 99
2025
Q3
$128K Sell
1,342
-281
-17% -$25.8K 0.06% 101
2025
Q2
$141K Buy
1,623
+1,334
+462% +$113K 0.07% 92
2025
Q1
$26K Buy
289
+12
+4% +$1.07K 0.02% 180
2024
Q4
$22.1K Sell
277
-1,297
-82% -$112K 0.01% 190
2024
Q3
$142K Buy
1,574
+14
+0.9% +$1.18K 0.08% 85
2024
Q2
$123K Buy
1,560
+14
+0.9% +$1.15K 0.07% 84
2024
Q1
$135K Buy
1,546
+12
+0.8% +$1.02K 0.08% 80
2023
Q4
$126K Buy
1,534
+14
+0.9% +$1.07K 0.09% 83
2023
Q3
$119K Buy
1,520
+12
+0.8% +$1K 0.1% 71
2023
Q2
$133K Buy
1,508
+13
+0.9% +$1.12K 0.1% 70
2023
Q1
$121K Buy
1,495
+12
+0.8% +$978 0.09% 88
2022
Q4
$115K Buy
1,483
+12
+0.8% +$973 0.09% 71
2022
Q3
$119K Buy
1,471
+12
+0.8% +$1.08K 0.1% 62
2022
Q2
$131K Buy
1,459
+8
+0.6% +$811 0.11% 61
2022
Q1
$161K Buy
1,451
+9
+0.6% +$951 0.11% 63
2021
Q4
$149K Sell
1,442
-88
-6% -$10.2K 0.09% 65
2021
Q3
$192K Sell
1,530
-5
-0.3% -$647 0.14% 52
2021
Q2
$191K Sell
1,535
-18
-1% -$2.26K 0.14% 50
2021
Q1
$183K Sell
1,553
-10
-0.6% -$1.17K 0.15% 50
2020
Q4
$183K Buy
1,563
+7
+0.4% +$771 0.16% 49
2020
Q3
$162K Buy
1,556
+9
+0.6% +$904 0.15% 48
2020
Q2
$142K Buy
1,547
+35
+2% +$3.36K 0.16% 46
2020
Q1
$136K Buy
1,512
+21
+1% +$2.23K 0.16% 39
2019
Q4
$169K Buy
+1,491
New +$164K 0.18% 42

Other funds holding MDT

HighMark Wealth Management's MDT Position: Q1 2026 in Review

HighMark Wealth Management increased its Medtronic (MDT) stake by 3.3% in Q1 2026, buying an estimated $4.31K and bringing the position to 1,397 shares worth $121K. The position accounts for 0.05% of the portfolio, ranked #101.

HighMark Wealth Management first reported a position in MDT in Q4 2019 and has held it in 26 quarters since. The position peaked at $192K in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • HighMark Wealth Management held 1,397 shares of Medtronic worth $121K as of Q1 2026.
  • HighMark Wealth Management bought 45 Medtronic shares in Q1 2026, an estimated $4.31K.
  • Medtronic made up 0.05% of HighMark Wealth Management's portfolio in Q1 2026, its #101 holding.
  • HighMark Wealth Management first reported a position in Medtronic in Q4 2019 and has held it in 26 quarters since.
  • HighMark Wealth Management's Medtronic position peaked at $192K in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on HighMark Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.